Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2018; 14(04): 298-299DOI: 10.1055/a-0737-3122 Studienreferate Georg Thieme Verlag KG Stuttgart · New York Kommentar Recommend Article Abstract Buy Article All articles of this category Comment on: Protonenpumpeninhibitoren und Aspirin in der Behandlung des Barrett-ÖsophagusGastroenterologie up2date 2018; 14(04): 298-298DOI: 10.1055/a-0737-3177 Full Text References Literatur 1 Kastelein F, Spaander MC, Steyerberg EW. et al. ProBar Study Group. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrettʼs esophagus. Clin Gastroenterol Hepatol 2013; 11: 382-388 2 Nguyen T, Duan Z, Naik AD. et al. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrettʼs esophagus: a nested case-control study. Gastroenterology 2015; 149: 1392-1398
